ASCO 2013 - Poster: Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302

CHICAGO, IL USA (UroToday.com) - Presented by Charles J. Ryan,¹ Anil Londhe,² Arturo Molina,³ Matthew R. Smith,⁴ Johann S. de Bono,⁵ Peter F.A. Mulders,⁶ Dana Rathkopf,⁷ Fred Saad,⁸ Christopher J. Logothetis,⁹ Karim Fizazi,¹⁰ Howard I. Scher,⁷ Eric J. Small,¹ Shannon Matheny,³ Thian Kheoh,³ and Thomas W. Griffin³ at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 31 - June 4, 2013 - McCormick Place - Chicago, IL USA

Click HERE to listen to a podcast by Charles Ryan, MD, one of the authors of this study

Click HERE to view the slide presentation from this session

¹Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; ²Janssen Research & Development, Raritan, NJ; ³Janssen Research & Development, Los Angeles, CA; ⁴Massachusetts General Hospital Center, Boston, MA; ⁵Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK; ⁶Radboud University Medical Centre, Nijmegen, The Netherlands; ⁷Memorial Sloan-Kettering Cancer Center, New York, NY; ⁸University of Montréal, Montréal, Québec, Canada; ⁹MD Anderson Cancer Center, Houston, TX; ¹⁰Institut Gustave Roussy, University of Paris Sud, Villejuif, France

View Full ASCO 2013 Coverage